ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $176,000 | -30.4% | 14,129 | -23.5% | 0.00% | -50.0% |
Q3 2016 | $253,000 | +48.8% | 18,460 | -19.9% | 0.00% | +100.0% |
Q2 2016 | $170,000 | +20.6% | 23,057 | +4.7% | 0.00% | 0.0% |
Q1 2016 | $141,000 | +35.6% | 22,030 | +31.8% | 0.00% | 0.0% |
Q4 2015 | $104,000 | -18.8% | 16,714 | -23.9% | 0.00% | 0.0% |
Q3 2015 | $128,000 | +124.6% | 21,964 | +217.5% | 0.00% | – |
Q2 2015 | $57,000 | +29.5% | 6,917 | +28.3% | 0.00% | – |
Q1 2015 | $44,000 | +18.9% | 5,390 | +0.2% | 0.00% | – |
Q4 2014 | $37,000 | +5.7% | 5,381 | -15.8% | 0.00% | – |
Q3 2014 | $35,000 | -14.6% | 6,394 | 0.0% | 0.00% | – |
Q2 2014 | $41,000 | -28.1% | 6,394 | -9.5% | 0.00% | -100.0% |
Q1 2014 | $57,000 | +21.3% | 7,068 | +2.2% | 0.00% | – |
Q4 2013 | $47,000 | -89.3% | 6,917 | -71.0% | 0.00% | -100.0% |
Q3 2013 | $439,000 | +100.5% | 23,867 | +90.7% | 0.00% | +100.0% |
Q2 2013 | $219,000 | – | 12,517 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |